SYS-6006

N/A

Report date: 2026/04/30 20:00:20

Base Information

Drug NameSYS-6006
Drug Alias NameSYS-6006
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co LtdJushi Biopharmaceutical Co Ltd
Inactive CompaniesCSPC Pharmaceutical Group Ltd
Active IndicationsCoronavirus Disease 2019 (COVID-19)Solid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A